Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Masitinib in Severe Persistent Asthma
NCT01449162Phase 3Completed
- Sponsor
- AB Science
- Start
- Jan 2011
- Primary completion
- Nov 2019
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 3 trial of masitinib in asthma, sponsored by AB Science. Started Jan 2011; status: completed.
02
Drugs
masitinib
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01449162.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01449162.